Literature DB >> 16143147

C-reactive protein: anti-placebo or predictor of response.

James D Lewis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16143147     DOI： 10.1053/j.gastro.2005.07.041

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

Review 1.  Future biologic targets for IBD: potentials and pitfalls.

Authors:  Gil Y Melmed; Stephan R Targan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

Review 2.  The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.

Authors:  James D Lewis
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 3.  A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease.

Authors:  Seyed Saeid Seyedian; Forogh Nokhostin; Mehrdad Dargahi Malamir
Journal:  J Med Life       Date:  2019 Apr-Jun

4.  An evidence-based review of natalizumab therapy in the management of Crohn's disease.

Authors:  Raja Gr Edula; Michael F Picco
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.